3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
4
Neoplasms
3
Breast Neoplasms
3
Papillomavirus Infections
2
Lung Neoplasms
2
Uterine Cervical Diseases
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Pulmonary Atelectasis
1
Postural Orthostatic Tachycardia Syndrome
1
Postoperative Complications
1
Pneumonia
1
Pancreatic carcinoma, familial
1
Pancreatic cancer, adult
1
Multiple Myeloma
1
Mastocytosis
1
Lung Cancer Screening
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
HIV Infections
1
Financial Stress
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cervical Cancer Screening
1
Bronchopulmonary Disease
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
59
Cisplatin
45
Cetuximab
29
Radiotherapy
26
Carboplatin
24
Docetaxel
17
Paclitaxel
16
Nivolumab
16
Surveys and Questionnaires
15
Radiotherapy, Intensity-Modulated
13
Fluorouracil
12
Drug Therapy
12
Blood Specimen Collection
11
Standard of Care
8
tislelizumab
7
cemiplimab
6
atezolizumab
6
Radiation
6
Chemoradiotherapy
6
toripalimab
5
Cyclophosphamide
5
130-nm albumin-bound paclitaxel
5
nimotuzumab
4
fludarabine
4
durvalumab
4
dostarlimab
4
Surgical Procedures, Operative
4
Afatinib
4
palbociclib
3
niraparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Mass Screening
×
1 year
×
Clear all
No trials found.